BlogZone Get the app
Finance

Aim ImmunoTech CEO & President Thomas Equels buys $4,862 in stock

BlogZone shows headlines and summaries from public news feeds. The full story is published by Investing.com.

Read the full story at Investing.com →

Enjoyed this?

Get more stories like this — and write your own — in the BlogZone app.

Get the app

More in Finance